Vijay Patel
Nephrology · Tampa, FLNPI 1124136676
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,900 of the $7,027 with a category attached, or 69.7%. AstraZeneca accounts for 77.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $4,387 and has fallen 98.1% since, to $84 in 2025.
Across 63 payments — averaging $111.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- Abbott$348
- Otsuka America Pharmaceutical, Inc.$301
- Genentech USA, Inc.$118
- Bayer$115
- Intuity Medical Inc$103
- plus $624 from 14 others
Across 6 payments — averaging $3654.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$16K
- Daiichi Sankyo Inc.$6K
What the payments were for
- Speaking & faculty fees$4,90070%
- Travel & lodging$4136%
- Food & beverage$1,64423%
- Education$701%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 21 | $5,419 |
| Abbott | 2 | $348 |
| Otsuka America Pharmaceutical, Inc. | 9 | $301 |
| Genentech USA, Inc. | 2 | $118 |
| Bayer | 4 | $115 |
| Intuity Medical Inc | 1 | $103 |
| CSL Behring | 1 | $102 |
| Dendreon Pharmaceuticals LLC | 1 | $84 |
| Fresenius USA Marketing, Inc. | 4 | $79 |
| OPKO Pharmaceuticals, LLC | 3 | $51 |
| Aurinia Pharma U.S., Inc. | 3 | $50 |
| Amgen(2 entities) | 2 | $45 |
| Baxter Healthcare | 2 | $44 |
| Biomerieux Inc | 2 | $39 |
| Travere Therapeutics, Inc. | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Novo Nordisk | 1 | $24 |
| Sanofi | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,027 in reported general payments places this provider in the 85th percentile of 756 nephrology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $6,197 |
| Divalproex Sodium | 14 | $917 |
| Mirtazapine | 19 | $407 |
| Haloperidol | 16 | $306 |
| Trazodone Hcl | 21 | $284 |
| Levothyroxine Sodium | 19 | $277 |
| Lorazepam | 24 | $232 |
| Morphine Sulfate | 17 | $230 |
| Tamsulosin Hcl | 22 | $158 |
| Azithromycin | 15 | $140 |
| Quetiapine Fumarate | 12 | $107 |
| Metoprolol Tartrate | 13 | $100 |
| Ciprofloxacin Hcl | 15 | $96 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $56 |
| Hydralazine Hcl | 12 | $46 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Tampa
- Sean VermaTampa$16K
- Arvind MadanOrlando$943K
- John CopleyWeston$934K
- Jorge LarranagaKissimmee$825K
- Carlos BejarFort Lauderdale$530K
- Wayne KotzkerFort Lauderdale$472K
- Jason RothschildTemple Terrace$413K
- Daniel PatelDaytona Beach$227K
- Rafael Baez BonillaFort Lauderdale$175K
- Gabriel ContrerasMiami$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.